Study of Glutamine as Prophylaxis for Irinotecan Induced Diarrhea
Interventional
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment
Reduction in diarrhea.
Study completion
No
Michael Sawyer, MD
Principal Investigator
Alberta Health Services
Canada: Health Canada
GI-05-0024
NCT00255229
December 2002
January 2010
Name | Location |
---|